Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 144,618 | 168,405 | 148,494 | 77,610 | 43,636 |
| Cost of Goods | 63,911 | 85,432 | 66,578 | 22,302 | 17,110 |
| Gross Profit | 80,707 | 82,973 | 81,916 | 55,308 | 26,526 |
| Operating Expenses | 729,397 | 758,776 | 1,767,229 | 82,282 | 86,581 |
| Operating Income | -647,779 | -675,371 | -1,684,735 | -26,672 | -59,945 |
| Interest Expense | 0 | 0 | 1,898 | 0 | 0 |
| Other Income | -22,836 | 82,594 | 80,955 | -75,940 | 5,050 |
| Pre-tax Income | -670,615 | -592,777 | -1,605,678 | -102,612 | -54,895 |
| Income Tax | -45 | -184 | -683 | -207 | -431 |
| Net Income Continuous | -670,570 | -592,593 | -1,604,995 | -102,405 | -54,464 |
| Minority Interests | -1,745 | -2,088 | -4,339 | -524 | -523 |
| Net Income | $-668,825 | $-590,505 | $-1,600,656 | $-101,881 | $-53,941 |
| EPS Basic Total Ops | -16.40 | -14.80 | -46.80 | -3.20 | -1.60 |
| EPS Basic Continuous Ops | -16.55 | -14.75 | -46.93 | -3.09 | -1.69 |
| EPS Diluted Total Ops | -16.40 | -14.80 | -48.40 | -3.20 | -1.60 |
| EPS Diluted Continuous Ops | -16.55 | -14.75 | -46.91 | -3.09 | -1.69 |
| EBITDA(a) | $-637,747 | $-666,431 | $-1,676,732 | $-18,393 | $-52,780 |